Literature DB >> 33681644

Super refractory status in a case of Febrile Infection-Related Epilepsy Syndrome due to hemophagocytic lymphocytic histiocytosis.

Salvadeeswaran Meenakshi-Sundaram1, Muthukani Sankaranarayanan1, Murugan Jeyaraman2, Chitra Ayyappan2, Somalinga Nagendran Karthik1, Suresh Pandi1.   

Abstract

A 14-year-old boy presented with a prodromal respiratory infection followed by super refractory status epilepticus. A diagnosis of Febrile Infection-Related Epilepsy Syndrome (FIRES) was made. Initial MRI study and CSF analysis were normal. He required multiple anticonvulsants owing to the refractory nature of the seizures. The course of the illness was rather stormy, laced with various medical problems viz. hepatic dysfunction, sepsis, hemodynamic, and hematological abnormalities which posed several challenges in the management. Hemophagocytic lymphocytic histiocytosis (HLH) was identified as the etiology of the illness and was treated but without success. The case report highlights the several immunomodulatory strategies that were employed to treat the disease, despite which the outcome was unfavorable.
© 2020 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.

Entities:  

Keywords:  Febrile Infection‐Related Epilepsy Syndrome; anticonvulsant polytherapy; hemophagocytic lymphocytic histiocytosis; immunomodulation; super refractory status epilepticus

Mesh:

Substances:

Year:  2021        PMID: 33681644      PMCID: PMC7918320          DOI: 10.1002/epi4.12454

Source DB:  PubMed          Journal:  Epilepsia Open        ISSN: 2470-9239


  16 in total

1.  HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.

Authors:  Jan-Inge Henter; Annacarin Horne; Maurizio Aricó; R Maarten Egeler; Alexandra H Filipovich; Shinsaku Imashuku; Stephan Ladisch; Ken McClain; David Webb; Jacek Winiarski; Gritta Janka
Journal:  Pediatr Blood Cancer       Date:  2007-02       Impact factor: 3.167

2.  Familial and acquired hemophagocytic lymphohistiocytosis.

Authors:  Gritta Janka; Udo zur Stadt
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

3.  Prolonged status epilepticus: Early recognition and prediction of full recovery in a 12-year cohort.

Authors:  Raoul Sutter; Saskia Semmlack; Peter W Kaplan; Petra Opić; Stephan Marsch; Stephan Rüegg
Journal:  Epilepsia       Date:  2018-11-22       Impact factor: 5.864

4.  New-onset refractory status epilepticus: Etiology, clinical features, and outcome.

Authors:  Nicolas Gaspard; Brandon P Foreman; Vincent Alvarez; Christian Cabrera Kang; John C Probasco; Amy C Jongeling; Emma Meyers; Alyssa Espinera; Kevin F Haas; Sarah E Schmitt; Elizabeth E Gerard; Teneille Gofton; Peter W Kaplan; Jong W Lee; Benjamin Legros; Jerzy P Szaflarski; Brandon M Westover; Suzette M LaRoche; Lawrence J Hirsch
Journal:  Neurology       Date:  2015-08-21       Impact factor: 9.910

5.  Fueling the FIRES: Hemophagocytic lymphohistiocytosis in febrile infection-related epilepsy syndrome.

Authors:  Raquel Farias-Moeller; Reghann LaFrance-Corey; Luca Bartolini; Elizabeth M Wells; Meredith Baker; Alyssa Doslea; William Suslovic; Jay Greenberg; Jessica L Carpenter; Charles L Howe
Journal:  Epilepsia       Date:  2018-08-22       Impact factor: 5.864

Review 6.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

7.  Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study.

Authors:  Elisabet Bergsten; AnnaCarin Horne; Maurizio Aricó; Itziar Astigarraga; R Maarten Egeler; Alexandra H Filipovich; Eiichi Ishii; Gritta Janka; Stephan Ladisch; Kai Lehmberg; Kenneth L McClain; Milen Minkov; Scott Montgomery; Vasanta Nanduri; Diego Rosso; Jan-Inge Henter
Journal:  Blood       Date:  2017-09-21       Impact factor: 22.113

8.  Refractory status epilepticus: a prospective observational study.

Authors:  Jan Novy; Giancarlo Logroscino; Andrea O Rossetti
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

9.  Bortezomib-Responsive Refractory Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Ramona Cordani; Concetta Micalizzi; Thea Giacomini; Matteo Gastaldi; Diego Franciotta; Francesca Fioredda; Silvia Buratti; Giovanni Morana; Daniela Pirlo; Salvatore Renna; Elio Castagnola; Marco Risso; Paola Lanteri; Maria Stella Vari; Maria Margherita Mancardi
Journal:  Pediatr Neurol       Date:  2019-10-19       Impact factor: 3.372

10.  Ketogenic Diet in Super-Refractory Status Epilepticus.

Authors:  Garnett Smith; Craig A Press
Journal:  Pediatr Neurol Briefs       Date:  2017-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.